Draduce an 'A 6 E' lesion. 15 of 44 s e r o t v~a b l c EPEC s t r a i n s and 6 o f 297 E. c o l i i s o l a t e s were p o s i t i v e i n the FAS t e s t . ~i i 6 FAS Test-positive E.coli were subsequently sirown t o adhere a l s o t o cultured human s n a i l i n t e s t i n a l mucosa and t o produce an 'A 6 E' leion. Only 1 of the 6 was subsequently found t o belong t o a c l a s s i c a l EPEC serogroup (0127). These r e s u l t s show: 1. The FAS t e s t i d e n t i f i e s 'A 6 E' E. c o l i which would not have been detected bv serotvuina. These 'A 6 E' E.coli which belong t o non-classical EPEC serograups.are " 0; ; p;obably human E.coli pathogens which have previously gone unrecagnised. 2. There i s no c o r r e l a t i o n between EPEC serotyping and the a b i l i t y t o cause t h e 'A & E' lesion.
c o r r e l a t i o n between EPEC serotyping and the a b i l i t y t o cause t h e 'A & E' lesion.
The FAS Test i s a useful a d d i t i o n t o the current range o f diagnostic t e s t s
f o r human E. c o l i e n t e r i c pathogens.
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DA w i y , w TSJ, DE b to m t r u l s althk was a l y s m f i c a n t in g w~p ELP.
It is mluded mt WE! anbination of m t e d protein rralrutritj.cn ard etharol -re in utero a l t e n WE W a t i c n of EL;F processing in developiq kpatccyte~ which my retard kptocellular mtumtion ard developmt. 00 Roep, RE ~o n t r o~, CBHW ~a m e r s , L3 Dooren, ~3 ~oedemaeker Depts Pediatrics,Gastroent.erologyandPathology, University Hospital Leiden, andPrimateCentrumTN0, Rijswijk,The Netherlands.
P r e v i a studies a t DNA ard prcduct level of B c e l l 1 ines on CD p a t i e n t s have s h m a strcng asscciaticn betweenCD nd t h e HLA-W2.3 ard IILA-CQ 87. .7 a l l e l e s 1 . The r a t rronalcnal SFH-2.O& which s p e c i f i c a l l y reccgnizes theHLA--2.3 specificity2ard themoncclonal directed aqainst theHLA-DPB2.7 specif i c i t v (M2 Mazzili,Italv) have beenused t o d e t e c t t h e~~r e s s ' i o n octhese s p & i f l c i t i e s a t ~~C S I M m 7 CDpaticnts ard 6 ncn-CD patients. The msernoncclcnal SW-L3 against HLA-CQ h c kb e was used as p c s i t i v e inmunqeraidase control. An imruncperoxidase technique cn frozen t i s s u e sections of jejunal bicpsy specimen was used.
~e s u l t s : Positivespocimms s h a r e d m Gfllt-rat ikof kit ~v c lylrdccyt e s a r d h~s t i c c v t e s in thc h m a p r o~r i a .
P o s i t i v c r e s u l t s a t t h c i n t e s t i n a l l t . & l c m e l a t e d w i t h G t y p i n g o f t h e p a t i e n t s andccntrols.
The e p i t h e l i a l c e l l s were negat ive.
Peripheral blocd Small intestine DR3DR7DR3/7DR-/-W2 D32.3 CQP2.7 CQ CD 5 5 3 0 7 6 7 7 Control 1 0 0 5 1 3 1 6 Ccnclusion: The r o u l t s show t h a t a t l n t e s t l n a l level t h e LILA-CQ spoclf IC a l l e l e s a s s o c i a t e d w1thCD a r c n c t e q r e s s d m t h e c p i t h e l i a l c e l l s but aburdantlv Dresent i n lamina ~r m r i a C e l l s of celiac-at ients. This d i s t r b t i o n &support t h e hypdth&is t h a t these CQmofmles a r e i nwlvd in the regulationof t h e i n t e s t i n a l imrmne respcmse togluten. 
and Masahiko Tohma2, Departmen; of ~e d i a t r i c r , '~u n t e n d o University, Tokvo. Hioashi-Niooon-Cakucn U n i v e r s i t v o f Hokkaido. Jaoan2. I n order t o c l a r i t v ' t h e -b i l e ac'ib metabolism durinq i h e neonatal i e r i b d . we measured f e t a l b i l e acids i n t h e u r i n e o f f u l l term neonates using s p e c i f i c q u a n t i t a t i v e assay by c a p i l l a r y CC w i t h negative i o n chemical i o n i z a t i o n MS. Spot u r i n e samples o f 15 f u l l term neonates were taken 1-5 days a f t e r b i r t h . As controls, spot u r i n e samples o f 10 h e a l t h c h i l d r e n aged 4-8 years were analysed. B i l e acids were extracted from u r i n e using Bond-Elut CI8 cartridge.
A f t e r s o l v o l y s i s and a l k a l i n e hydrolysis, t h e f r e e b i l e a c i d r were d e r i v o t i r e d t o the p e n t a f l u~r o b e n r~l ester and t k i m e t h y l s i l y l ether.
In the neonates, t h e percentage o f t o t a l 1)-hydronylated b i l e acids was s i g n i f i c a n t l y higher than t h a t i n the older children. The percentages of 36, 1%-5-cholenic a c i d and hyacholic a c i d i n the neonates were h i g h compared t o those i n t h e older children. The r a t i o s o f l g -CA/CA and 10 -CDCA/CDCA i n the neonates were s i g n i f i c a n t l y higher than those i n the older children.
The r a t i o s of CA/CDCA and 9 , l ? y -5-cholenoic a c i d / b -5-cholenoic a c i d were a l s o s i g n i f i c a n t l y higher i n the neonates than those i n t h e older children. of Craz. Austria The introduction of halogenated analogs of iminodiacetic acid (IDA) has increased the effectivity of cholescintigraphy in the different~al diagnosis of extrahepatic biliary atresia (EHBAI. We attempted t o evaluate cholescintigraphy with regard to its potential in increasing t h e effectivity and predictive value in t h e diagnosis of EHBA.
I t suggests t h a t Ip and
We studied 16 patients ( 3 with EHBA, weight = 2,454 kg,direct bilirubin 1.6-17.9 mgldl) by 18 tests. 99mTc mebrofenin ( n = 5 ) and 99mTc lodida (n=131 were used a s tracers in intermittant sequential scintigraphy to 2U h r s . The data were evaluated by a computer program to obtain 13 kinetic parameters, and were compared with the results of t h e conventional scintigraphic interpretation.
The positive predictive value of t h e test increased to 80 % by measurement of the maximum intestinal activity, and to 100 % by evaluation of the hepatic tracer clearance. Combining the maxlrnum intestinal activity with t h e hepatic tracer retention o r clearance led to an effectivity and positive predictive value of 100 %. The examination of liver indices L+ adjustment for background activity) had no value. Conclusions: An automated evaluation of data characterizing t h e excretion of halogenated IDA derivatives into the intestine has t h e potential of allowing the differentiation of EHBA from introhepatic diseases with high probability.We plan to perform prospective studies on larger numbers of infants. Conclusions I n circumstances i n which HBlC i s not available a 4 dose vaccine schedule can protect a t r i s k infants from p e r i n a t a l transmission of HBV. I n babies born t o the less i n f e c t i o u s c a r r i e r mothers i n our study (i.e. those n o t HBe Agt) t h e a d d i t i o n o f HBlC t o the schedule conferred no added b e n e f i t . I n i n f a n t s born t o HBe Ag+ mothers p r o t e c t i o n w a r enhanced by a d d i t i o n o f HB1C although transmission was s t i l l not prevented i n every care. I n utero i n f e c t i o n and $10. response t o vaccine may be implicated f a i l u r e mechanisms.
